Mass screening program for prostate cancer in urban area of Kyoto
Kitamura, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl. 5: 212-216
2011
ISSN/ISBN: 0047-1852 PMID: 22207973 Document Number: 652452
Document emailed within 1 workday
Related Documents
Altarac, S. 2013: Individualized "opportunistic" screening for prostate cancer instead of mass population screening Lijecnicki Vjesnik 135(1-2): 51-52Komeda, Y.; Suzuki, R.; Maeda, Y.; Okabe, S.; Kawamura, J.; Hioki, T.; Ohawa, M. 1994: Mass screening for prostate cancer at a local town--five-year results and screening system Hinyokika Kiyo. Acta Urologica Japonica 40(4): 315-318
Akamatsu, N.; Ide, M.; Ueda, Y.; Kondo, Y.; Nakamura, S.; Mori, T.; Ogimoto, I.; Yoshimura, T. 1986: A population survey on mass screening program for gastric cancer part 1. population characteristics related to examination rates for screening program Journal of UOEH 8(2): 177-184
Trehu, E.G.; Cooper, J.N. 1992: Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature Southern Medical Journal 85(3): 248-254
Ito, K.; Yamamoto, T.; Kubota, Y.; Yamanaka, H. 2000: Mass screening for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 365-368
Imai, K.; Kubota, H. 1998: Mass screening for prostate cancer--how to eliminate clinically insignificant cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(6): 809-812
Koga, H.; Yamaguchi, A.; Miyazaki, Y.; Naito, S. 2011: Action assignment of mass screening for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 5): 217-220
Ito, K.; Ohtake, N.; Hatori, M.; Mashimo, T.; Jimbo, S.; Tomaru, Y.; Makino, T.; Yajima, H.; Imai, K.; Yamanaka, H. 1992: Prostatic specific antigen (PA) in mass screening for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1225-1229
Fujimoto, I. 1984: Mass screening program for cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3 Pt 2): 727-732
Myers, R.E.; Vernon, S.W.; Carpenter, A.V.; Balshem, A.M.; Lewis, P.G.; Wolf, T.A.; Hilbert, J.; DeFonso, L.R.; Ross, E.A. 1997: Employee response to a company-sponsored program of colorectal and prostate cancer screening Cancer Detection and Prevention 21(4): 380-389
Spee, M.H.; van Gastel, J. 1992: Evaluation of the organization of the mass screening program for cervix cancer in northern Limburg Nederlands Tijdschrift Voor Geneeskunde 136(47): 2327-2331
Liu, X.; Zheng, S.; Chen, K.; Ma, X.; Zhou, L.; Yu, H.; Yao, K.; Chen, K.; Cai, S.; Zhang, S. 2000: Randomized controlled trial of sequence mass screening program for colorectal cancer Zhonghua Liu Xing Bing Xue Za Zhi 21(6): 430-433
Núñez-Troconis, J.é; Tulliani, E.; Gabriela Martínez, M.ía.; Fernández, N. 2013: Knowledge and attitudes as predictors of cervical cancer screening among women in a Venezuelan urban area Investigacion Clinica 54(1): 20-33
Salem, A.; Debabria, H.; Mehiri, S.; Driss, M.; Kribi, L.; Sellemi, M.; Mrad, K.; Hamza, R.; Mnif, N.; Ben Romdhane, K.; Zaanouni, E.; Gueddana, N. 2009: Retrospective results of ultrasonographically-guided biopsy the breast cancer screening program of the Ariana area of Tunisia La Tunisie Medicale 87(7): 463-470
Wang, X.; Wang, A-rong.; Fan, J-chuan.; Li, J.; Bao, Y.; Wang, Y.; Yang, Q-feng.; Ren, Y. 2012: Results of a screening program on high incidence area of esophageal cancer in Yanting Sichuan from 2006 to 2011 Zhonghua Liu Xing Bing Xue Za Zhi 33(8): 784-787
Plowden, K.O. 2006: To screen or not to screen: factors influencing the decision to participate in prostate cancer screening among urban African-American men Urologic Nursing 26(6): 477-82: Discussion 483-5 489
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
O'Dell, K.J.; Volk, R.J.; Cass, A.R.; Spann, S.J. 1999: Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? Journal of Family Practice 48(9): 682-688
Parkes, C.; Wald, N.J.; Murphy, P.; George, L.; Watt, H.C.; Kirby, R.; Knekt, P.; Helzlsouer, K.J.; Tuomilehto, J. 1995: Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer BMJ 311(7016): 1340-1343